1. FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor. Issue 3 (6th May 2021) Authors: Sun, Qian; Novak, Daniel; Hüser, Laura; Poelchen, Juliane; Wu, Huizi; Granados, Karol; Federico, Aniello; Liu, Ke; Steinfass, Tamara; Vierthaler, Marlene; Umansky, Viktor; Utikal, Jochen Journal: International journal of cancer Issue: Volume 149:Issue 3(2021) Page Start: 657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗